Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A With Inhibitor”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Large-scale testing (Phase 3)UnknownNCT06155955
What this trial is testing

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Who this might be right for
Severe Hemophilia A Without InhibitorJoint Bleed
Chulalongkorn University 15
Post-approval studies (Phase 4)UnknownNCT03136003
What this trial is testing

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Who this might be right for
Mild Haemophilia A Without Inhibitor
The Hospital for Sick Children 30
Post-approval studies (Phase 4)Looking for participantsNCT05888870
What this trial is testing

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Who this might be right for
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China 50
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Post-approval studies (Phase 4)Looking for participantsNCT04647227
What this trial is testing

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network 55
Post-approval studies (Phase 4)Study completedNCT00323856
What this trial is testing

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Grifols Biologicals, LLC 51
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Post-approval studies (Phase 4)Study completedNCT01800435
What this trial is testing

A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor

Who this might be right for
Hereditary Factor VIII Deficiency Disease With Inhibitor
Oslo University Hospital 6
Post-approval studies (Phase 4)Looking for participantsNCT07406139
What this trial is testing

PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）

Who this might be right for
HemophiliaInhibitors
Institute of Hematology & Blood Diseases Hospital, China 30
Post-approval studies (Phase 4)UnknownNCT04621916
What this trial is testing

Preventing Inhibitor Recurrence Indefinitely

Who this might be right for
Hemophilia AImmune Tolerance
Children's Hospital Los Angeles 52
Not applicableNot Yet RecruitingNCT07791836
What this trial is testing

Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study

Who this might be right for
Hemophilia AHemophilia
AryoGen Pharmed Co. 262
Not applicableStudy completedNCT04181697
What this trial is testing

HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Oslo University Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Not applicableNot Yet RecruitingNCT07200609
What this trial is testing

The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia

Who this might be right for
Hemophilia A Without Inhibitor
Hacettepe University 20
Next Page